×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [van cutsem e]
Xeloda versus 5-FU/LV in adjuvant colon cancer: whats your conclusion? David Kerr University of Oxford Oxford, UK
212 views
Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC) Eric Van Cutsem, MD, PhD University Hospitals Gasthuisberg/Leuven, Leuven,
219 views
G. Folprecht,* M. Nowacki , I. Lang, S. Cascinu ,
27 views
DATECAN PROJECT 1 Guidelines for endpoint definitions in cancer trials Bonnetain F DATECAN Project on behalf DATECAN steering committee Statisticians from
214 views
ASCO Annual Meeting 2012
29 views
Disclosure – Thierry André
31 views
Eric Van Cutsem, 1 Cathy Eng, 2 Josep Tabernero, 3 Elzbieta Nowara, 4 Anna Świeboda-Sadlej, 5
70 views
Phase III CORRECT trial of regorafenib in metastatic colorectal cancer ( mCRC )
54 views
Clinicaloptions.com/oncology Expert Insight Into the First-line Treatment of Metastatic Colorectal Cancer KRAS Status in Response to Cetuximab Retrospective
217 views
Carmen Allegra,*
61 views